-+ 0.00%
-+ 0.00%
-+ 0.00%

Fulcrum Therapeutics Price Target Raised to $25.00/Share From $18.00 by HC Wainwright & Co.

Dow Jones·12/08/2025 12:50:00

Please log in to view news